Royce & Associates’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $478K | Sell |
29,893
-152,291
| -84% | -$2.44M | ﹤0.01% | 717 |
|
|
2025
Q1 | $3.54M | Sell |
182,184
-130,000
| -42% | -$2.53M | 0.04% | 496 |
|
|
2024
Q4 | $6.88M | Sell |
312,184
-398,303
| -56% | -$8.77M | 0.06% | 416 |
|
|
2024
Q3 | $12M | Hold |
710,487
| – | – | 0.11% | 270 |
|
|
2024
Q2 | $8.49M | Sell |
710,487
-84,481
| -11% | -$1.01M | 0.08% | 362 |
|
|
2024
Q1 | $8.81M | Buy |
794,968
+34,268
| +5% | +$380K | 0.08% | 363 |
|
|
2023
Q4 | $6.59M | Hold |
760,700
| – | – | 0.06% | 429 |
|
|
2023
Q3 | $5.82M | Hold |
760,700
| – | – | 0.06% | 448 |
|
|
2023
Q2 | $5.48M | Buy |
760,700
+100,000
| +15% | +$720K | 0.05% | 475 |
|
|
2023
Q1 | $4.02M | Buy |
660,700
+100,000
| +18% | +$609K | 0.04% | 535 |
|
|
2022
Q4 | $2.44M | Buy |
+560,700
| New | +$2.44M | 0.03% | 618 |
|